Synonyms: | |
Status: | Approved (1974) |
Entry Type: | Small molecule |
Molecule Category: | Parent |
ATC: | N05AE02 |
UNII: | RT3Y3QMF8N |
InChI Key | KLPWJLBORRMFGK-UHFFFAOYSA-N |
---|---|
Smile | |
InChI |
|
Property Name | Value |
---|---|
Molecular Formula | C16H24N2O2 |
Molecular Weight | 276.38 |
AlogP | 1.96 |
Hydrogen Bond Acceptor | 3.0 |
Hydrogen Bond Donor | 1.0 |
Number of Rotational Bond | 3.0 |
Polar Surface Area | 45.33 |
Molecular species | NEUTRAL |
Aromatic Rings | 1.0 |
Heavy Atoms | 20.0 |
Primary Target | |
---|---|
5-HT2A receptor |
Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
---|---|---|---|---|---|---|
Membrane receptor
Family A G protein-coupled receptor
Small molecule receptor (family A GPCR)
Monoamine receptor
Dopamine receptor
|
- | - | - | 33-33 | - | |
Membrane receptor
Family A G protein-coupled receptor
Small molecule receptor (family A GPCR)
Monoamine receptor
Serotonin receptor
|
- | - | - | 1413-1413 | - |
Mesh Heading | Maximum Phase | Mesh ID | Reference |
---|---|---|---|
Attention Deficit Disorder with Hyperactivity | 3 | D001289 | ClinicalTrials |
Resources | Reference |
---|---|
CAS NUMBER | 7416-34-4 |
ChEBI | 6965 |
ChEMBL | CHEMBL460 |
DrugBank | DB01618 |
DrugCentral | 1830 |
EPA CompTox | DTXSID9023332 |
FDA SRS | RT3Y3QMF8N |
Human Metabolome Database | HMDB0015555 |
Guide to Pharmacology | 207 |
KEGG | C07230 |
PharmGKB | PA164746756 |
PubChem | 23897 |
SureChEMBL | SCHEMBL149233 |